Drug Safety Information for MEVACOR (Lovastatin)

Safety-related Labeling Changes for ALTOPREV (LOVASTATIN) Rx Drug: FDA Link

Adverse Drug Reactions for MEVACOR* (Lovastatin)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with MEVACOR
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Nausea756
2Drug ineffective746
3Dyspnoea669
4Dizziness*633
5Fatigue*601
6Pain*566
7Asthenia488
8Headache478
9Diarrhoea476
10Fall436
11Vomiting431
12Arthralgia*414
13Pain in extremity*401
14Anxiety382
15Myalgia*374
16Chest pain372
17Myocardial infarction356
18Weight decreased350
19Blood glucose increased340
20Oedema peripheral338

* This side effect also appears in "Top 10 Side Effects of MEVACOR " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking MEVACOR
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Blood cholesterol increased*6048
2Product used for unknown indication4481
3Blood cholesterol*1864
4Hypercholesterolaemia1267
5Hyperlipidaemia1015
6Blood cholesterol abnormal941
7Dyslipidaemia247
8Hypertension213
9Cardiac disorder161
10Blood triglycerides increased68

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for MEVACOR

Total Reports Filed with FDA: 57310


Number of FDA Adverse Event Reports by Patient Age for MEVACOR

Total Reports Filed with FDA: 57310*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Lovastatin (Mevacor, Altocor, Lovastatin, Altoprev)

Charts are based on 57310 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and MEVACOR Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on MEVACOR's side effects.